Biotech Values

[ghmm]

HALO:

I can't speak for all HALO investors but I don't think its the CRL per say its the (much further reaching) contents of the CRL and the fear of how far it reaches.

For those unfamiliar with HALO here is a summary of their products and if one believes management the impact:

Hylenex (Approved) - > not impacted
HyQvia (Baxter immunoglobulin with rHuPH20) -> on Hold
Herceptin SC, MabThera SC, Actemra SC (Roche) -> not impacted. Herceptin filled March '12. Mabthera planned filing later this year.
Cinryze (ViroPharma with rHuPH20) -> on Hold

Insulin-PH20 (Proprietary) -> no current trials but my impression the pump program (using Hylenex) would not be but others would be.
PEGPH20 (Proprietary) -> not impacted
HTI-501 (Proprietary) -> not impacted